[HTML][HTML] Fucosylated antigens in cancer: an alliance toward tumor progression, metastasis, and resistance to chemotherapy

A Blanas, NM Sahasrabudhe, E Rodriguez… - Frontiers in …, 2018 - frontiersin.org
Aberrant glycosylation of tumor cells is recognized as a universal hallmark of cancer
pathogenesis. Overexpression of fucosylated epitopes, such as type I (H1, Lewisa, Lewisb …

[HTML][HTML] Recent advances and future perspectives in the therapeutics of prostate cancer

GL Varaprasad, VK Gupta, K Prasad, E Kim… - … Hematology & Oncology, 2023 - Springer
Prostate cancer (PC) is one of the most common cancers in males and the fifth leading
reason of death. Age, ethnicity, family history, and genetic defects are major factors that …

[HTML][HTML] Prostate imaging-reporting and data system steering committee: PI-RADS v2 status update and future directions

AR Padhani, J Weinreb, AB Rosenkrantz, G Villeirs… - European urology, 2019 - Elsevier
Abstract Context The Prostate Imaging-Reporting and Data System (PI-RADS) v2 analysis
system for multiparametric magnetic resonance imaging (mpMRI) detection of prostate …

A novel and highly sensitive sandwich-type immunosensor for prostate-specific antigen detection based on MWCNTs-Fe3O4 nanocomposite

A Shamsazar, A Asadi, D Seifzadeh… - Sensors and Actuators B …, 2021 - Elsevier
Due to the importance of early diagnosis of prostate cancer, an ultrasensitive
electrochemical immunosensor was developed to detect prostate-specific antigen (PSA) …

Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer

J Tkac, V Gajdosova, S Hroncekova… - Journal of the …, 2019 - royalsocietypublishing.org
The initial part of this review details the controversy behind the use of a serological level of
prostate-specific antigen (PSA) for the diagnostics of prostate cancer (PCa). Novel …

Plasma exosomal miR-125a-5p and miR-141-5p as non-invasive biomarkers for prostate cancer.

W Li, Y Dong, KJ Wang, Z Deng, W Zhang… - …, 2020 - search.ebscohost.com
Predictive biomarkers for early diagnosis of prostate cancer are important for its treatment.
The functional microRNAs in the exosomes of plasma and serum samples are of interest as …

[HTML][HTML] Lanthanide MOF-based luminescent sensor arrays for the detection of castration-resistant prostate cancer curing drugs and biomarkers

X Wang, K Gopalsamy, G Clavier, G Maurin, B Ding… - Chemical …, 2024 - pubs.rsc.org
In recent years, castration-resistant prostate cancer (CRPC) has profoundly impacted the
lives of many men, and early diagnosis of medication and illness is crucial. Therefore, a …

Nurturing the marriages of urinary liquid biopsies and nano‐diagnostics for precision urinalysis of prostate cancer

C Liao, Z Wu, C Lin, X Chen, Y Zou, W Zhao… - Smart …, 2023 - Wiley Online Library
Prostate cancer remains the second‐most common cancer diagnosed in men, despite the
increasingly widespread use of serum prostate‐specific antigen (PSA) screening. The …

Identification of multisialylated LacdiNAc structures as highly prostate cancer specific glycan signatures on PSA

Y Haga, M Uemura, S Baba, K Inamura… - Analytical …, 2019 - ACS Publications
Serum prostate-specific antigen (PSA) test is the current gold standard for screening and
diagnosis of prostate cancer (PCa), while overdiagnosis and overtreatment are social …

based colorimetric sensors for point-of-care testing

A Ko, L Caizhi - Analytical Methods, 2023 - pubs.rsc.org
By eliminating the need for sample transportation and centralized laboratory analysis, point-
of-care testing (POCT) enables on-the-spot testing, with results available within minutes …